Award

COVID19RF‐0011

Funder: National Medical Research Council

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

Funded outputs count: 7

Funder award ID: COVID19RF‐0011

OpenAlex ID: G2902802498

Modeling Antibody Kinetics Post‐mRNA Booster Vaccination and Protection Durations Against SARS‐CoV‐2 Infection

2025 · Luis J. Ponce, Yuqian Wang, et al. · Journal of Medical Virology · 5

SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses

2025 · Weiyi Tang, Zi Wei Chang, et al. · Vaccines · 5

Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1)

2024 · Yun Shan Goh, Siew‐Wai Fong, et al. · International Journal of Infectious Diseases · 1

Relative deficiency in interferon‐γ‐secreting CD4+ T cells is strongly associated with poorer COVID‐19 vaccination responses in older adults

2024 · Vanda W. T. Ho, Low Heng Boon, et al. · Aging Cell · 4

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave

2023 · Yun Shan Goh, Siew-Wai Fong, et al. · Scientific Reports · 2

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain

2023 · Angeline Rouers, Matthew Zirui Tay, et al. · STAR Protocols · 9

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]

2022 · Xuan Ying Poh, I. Russel Lee, et al. · Trials · 6